ArticleJournal for immunotherapy of cancer2021

Correction: Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.